Advertisement

Advertisement

TELO Stock Latest News

Telomir Pharmaceuticals Regains Nasdaq Listing Rule Compliance

Company AnnouncementsTelomir Pharmaceuticals Regains Nasdaq Listing Rule Compliance

Telomir Pharmaceuticals submits IND to FDA for Telomir-1 in TNBC

PremiumThe Fly

Telomir Pharmaceuticals submits IND to FDA for Telomir-1 in TNBC

14d ago

Telomir Pharmaceuticals submits IND to FDA for Telomir-1 in TNBC

PremiumThe Fly

Telomir Pharmaceuticals submits IND to FDA for Telomir-1 in TNBC

14d ago

Telomir Shareholders Approve Equity Plan and Bylaw Changes

PremiumCompany Announcements

Telomir Shareholders Approve Equity Plan and Bylaw Changes

18d ago

Telomir Sets Vote on Transformative TELI Merger and Governance Changes

PremiumCompany Announcements

Telomir Sets Vote on Transformative TELI Merger and Governance Changes

2M ago

Telomir Pharmaceuticals announces in vitro data on Telomir-1

PremiumThe FlyTelomir Pharmaceuticals announces in vitro data on Telomir-1

2M ago

Telomir reveals promising preclinical data for Telomir-Zn

Company Announcements

Telomir reveals promising preclinical data for Telomir-Zn

2M ago

Telomir Pharmaceuticals reports cellular study results on Telomir-1

The Fly

Telomir Pharmaceuticals reports cellular study results on Telomir-1

2M ago

Telomir Pharmaceuticals Highlights Preclinical Data for Telomir-1

PremiumCompany Announcements

Telomir Pharmaceuticals Highlights Preclinical Data for Telomir-1

2M ago

Telomir Pharmaceuticals initiated with a Buy at Rodman & Renshaw

PremiumThe Fly

Telomir Pharmaceuticals initiated with a Buy at Rodman & Renshaw

3M ago

Telomir Pharmaceuticals reports results from efficacy study for Telomir-1

PremiumThe Fly

Telomir Pharmaceuticals reports results from efficacy study for Telomir-1

3M ago

Telomir Highlights Positive Preclinical Results for Telomir-1 in TNBC

PremiumCompany Announcements

Telomir Highlights Positive Preclinical Results for Telomir-1 in TNBC

3M ago

Telomir Pharmaceuticals reports results from safety studies for Telomir-1

PremiumThe FlyTelomir Pharmaceuticals reports results from safety studies for Telomir-1

4M ago

Telomir Pharmaceuticals Reports Positive IND-Enabling Study Results

Company Announcements

Telomir Pharmaceuticals Reports Positive IND-Enabling Study Results

4M ago

Telomir Pharmaceuticals announces new preclinical data on Telomir-1

The Fly

Telomir Pharmaceuticals announces new preclinical data on Telomir-1

5M ago

Telomir Pharmaceuticals Reports Promising Preclinical Data

PremiumCompany Announcements

Telomir Pharmaceuticals Reports Promising Preclinical Data

5M ago

Telomir Pharmaceuticals announces in vitro data on Telomir-1

PremiumThe Fly

Telomir Pharmaceuticals announces in vitro data on Telomir-1

5M ago

Telomir Pharmaceuticals’ Telomir-1 Shows Leukemia Efficacy

PremiumCompany Announcements

Telomir Pharmaceuticals’ Telomir-1 Shows Leukemia Efficacy

5M ago

Telomir Pharmaceuticals announces new preclinical data on Telomir-1

PremiumThe Fly

Telomir Pharmaceuticals announces new preclinical data on Telomir-1

5M ago

Telomir Pharmaceuticals Unveils Promising Preclinical Data

PremiumCompany AnnouncementsTelomir Pharmaceuticals Unveils Promising Preclinical Data

5M ago

Telomir says data shows Telomir-1 resets cancer ‘kill-and-clean’ defense system

The Fly

Telomir says data shows Telomir-1 resets cancer ‘kill-and-clean’ defense system

6M ago

Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data

Company Announcements

Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >